Literature DB >> 19222676

Will the results of the ACCOMPLISH trial affect the recommendations of JNC 8?

Debbie L Cohen1, Raymond R Townsend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19222676      PMCID： PMC8673244          DOI： 10.1111/j.1751-7176.2009.00075.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  A rationale for combination therapy in risk factor management: a mechanistic perspective.

Authors:  R Preston Mason
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.

Authors:  Helmy M Siragy; Chun Xue; Randy L Webb
Journal:  J Cardiovasc Pharmacol       Date:  2006-05       Impact factor: 3.105

4.  Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.

Authors:  X Zhang; T H Hintze
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

5.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.

Authors:  Joel M Neutel; David H G Smith; Michael A Weber
Journal:  Am J Hypertens       Date:  2004-01       Impact factor: 2.689

Review 8.  Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.

Authors:  T F Lüscher; R R Wenzel; P Moreau; H Takase
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.